WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 10 fonti

Kimberly-Clark to buy Kenvue in $48.7 billion deal

Kenvue's shareholders will receive $3.50 per share and 0.15 Kimberly-Clark shares for each Kenvue share held.

Raccontata da

handelsblatt.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

cnbc.comStai leggendo8 mesi fa

Kimberly-Clark to buy Kenvue in $48.7 billion deal

Kenvue's shareholders will receive $3.50 per share and 0.15 Kimberly-Clark shares for each Kenvue share held.

Timeline cronologica

lunedì 3 novembre 2025·handelsblatt.com
Konsumgüter: US-Konzern Kimberly-Clark kauft Kenvue für rund 49 Milliarden Dollar
Mit dem Deal entsteht ein riesiger Konzern für Gesundheits- und Pflegeprodukte. Kimberly-Clark bezahlt einen deutlichen Aufpreis gegenüber dem Aktienkurs von Kenvue.
lunedì 3 novembre 2025·cnbc.com
Kimberly-Clark to buy Kenvue in $48.7 billion deal
Kenvue's shareholders will receive $3.50 per share and 0.15 Kimberly-Clark shares for each Kenvue share held.

8 mesi fa

Kimberly-Clark agrees to purchase Kenvue for $48.7B - UPI.com

The Texas-based Kimberly-Clark Corporation announced Monday it reached a deal to purchase Kenvue for $48.7 billion.

Leggi questa versione → originale

bbc.com8 mesi fa

Kimberly-Clark buys Tylenol-maker Kenvue in more than $40bn deal

The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.

Leggi questa versione → originale

handelsblatt.com8 mesi fa

Konsumgüter: US-Konzern Kimberly-Clark kauft Kenvue für rund 49 Milliarden Dollar

Mit dem Deal entsteht ein riesiger Konzern für Gesundheits- und Pflegeprodukte. Kimberly-Clark bezahlt einen deutlichen Aufpreis gegenüber dem Aktienkurs von Kenvue.

Leggi questa versione → originale

usatoday.com8 mesi fa

Kimberly-Clark to buy Kenvue, maker of Tylenol, in $48 billion deal

Kimberly-Clark is buying Kenvue, the maker of Tylenol, after months of controversy around whether the medicine is linked to autism.

Leggi questa versione → originale

ansa.it8 mesi fa

Kimberly-Clark acquista produttore Kenvue per 40 miliardi - Ultima ora - Ansa.it

Kimberly-Clark, il colosso a cui fanno capo i Kleenex e gli Huggies, ha raggiunto un accordo per acquistare Kenvue, la società che produce il Tylenol, per 40 miliardi di dollari. (ANSA)

Leggi questa versione → originale

lunedì 3 novembre 2025·

cnbc.com

Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant

The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol.

lunedì 3 novembre 2025·

ansa.it

Kimberly-Clark acquista produttore Kenvue per 40 miliardi - Ultima ora - Ansa.it

Kimberly-Clark, il colosso a cui fanno capo i Kleenex e gli Huggies, ha raggiunto un accordo per acquistare Kenvue, la società che produce il Tylenol, per 40 miliardi di dollari.…

lunedì 3 novembre 2025·

ansa.it

Kimberly-Clark acquista produttore Kenvue per 40 miliardi - Notizie - Ansa.it

Kimberly-Clark, il colosso a cui fanno capo i Kleenex e gli Huggies, ha raggiunto un accordo per acquistare Kenvue, la società che produce il Tylenol, per 40 miliardi di dollari.…

lunedì 3 novembre 2025·

usatoday.com

Kimberly-Clark to buy Kenvue, maker of Tylenol, in $48 billion deal

Kimberly-Clark is buying Kenvue, the maker of Tylenol, after months of controversy around whether the medicine is linked to autism.

lunedì 3 novembre 2025·

forbes.com

Huggies Maker Buys Kenvue (Tylenol Maker) For $48 Billion

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.

lunedì 3 novembre 2025·

upi.com

Kimberly-Clark agrees to purchase Kenvue for $48.7B - UPI.com

The Texas-based Kimberly-Clark Corporation announced Monday it reached a deal to purchase Kenvue for $48.7 billion.

lunedì 3 novembre 2025·

bbc.com

Kimberly-Clark buys Tylenol-maker Kenvue in more than $40bn deal

The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.

lunedì 3 novembre 2025·

ft.com

Kimberly-Clark swoops on Tylenol maker Kenvue as US deal spree accelerates

$49bn tie-up comes on frantic day of mergers and acquisitions across corporate America

lunedì 3 novembre 2025·

elpais.com

El dueño de Kleenex compra la empresa de Tylenol y Neutrógena por casi 35.000 millones

Kimberly-Clark se hace con Kenvue, con marcas como Johnson’s o Listerine, una empresa a la que Trump acusa de vender un analgésico relacionado con el autismo

lunedì 3 novembre 2025·

aljazeera.com

Kimberly-Clark to buy Tylenol maker Kenvue for $40bn

The deal has analysts puzzled, as the US maker of Tylenol has seen sales dip after the White House linked it to autism.

martedì 4 novembre 2025·

cnbc.com

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

Kimberly-Clark CEO Mike Hsu discussed his company's $48.7 billion acquisition of Kenvue in a Monday interview with CNBC's Jim Cramer.